Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Madina Baranova"'
Autor:
Elena Poddubskaya, Alexey Bondarenko, Alexander Boroda, Evgenia Zotova, Alex Glusker, Svetlana Sletina, Luidmila Makovskaia, Philipp Kopylov, Marina Sekacheva, Alexey Moisseev, Madina Baranova
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Non-small cell lung carcinoma (NSCLC) is the major cause of cancer-associated mortality. Identification of rearrangements in anaplastic lymphoma kinase (ALK) gene is an effective instrument for more effective targeted therapy of NSCLC using ALK inhib
Externí odkaz:
https://doaj.org/article/3d23333a8b0547b39a90d02742d04e68
Autor:
Elena Poddubskaya, Maxim Sorokin, Marianna Zolotovskaya, Maria Suntsova, Andrew Garazha, Alexey Moisseev, Alexey Bondarenko, Vasiliy Skrijalin, Madina Baranova, Marina Sekacheva, Alexander Seryakov, Anton Buzdin
Publikováno v:
Journal of Clinical Oncology. 40:151-151
151 Background: Colorectal cancer (CRC) is the fourth most common cancer worldwide with relatively poor patient survival. Transcriptome assay could be used to personalize CRC treatment thus complementing standard mutation analysis. Methods: We perfor
Autor:
Madina Baranova, Daria Allina, Lali Kogoniya, Maria Suntsova, Andrew Garazha, Ekaterina Markarova, Victor Tkachev, Elena Poddubskaya, Maxim Sorokin, Anton Buzdin, Marina Sekacheva, Alex Glusker
Publikováno v:
Cold Spring Harbor Molecular Case Studies
Gastric cancer (GC) is the fifth-ranked cancer type by associated mortality. The proportion of early diagnosis is low, and most patients are diagnosed at the advanced stages. First-line therapy standardly includes fluoropyrimidines and platinum compo
Autor:
Alexey P. Kirilchev, Marina Sekacheva, Alexey Aleshin, Daria Allina, Maria Suntsova, Madina Baranova, Eugene Albert, Philipp Y. Smirnov, Elena Poddubskaya
Publikováno v:
Experimental Hematology & Oncology
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-7 (2018)
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-7 (2018)
Background Cholangiocarcinoma is an aggressive tumor with poor prognosis. Most of the cases are not available for surgery at the stage of the diagnosis and the best clinical practice chemotherapy results in about 12-month median survival. Several tyr
Autor:
Eugene Albert, Alexey Aleshin, Daria Allina, Elena Poddubskaya, Maria Suntsova, Madina Baranova, Lyudmila Makovskaia, Marina Sekacheva
Publikováno v:
Journal of Clinical Oncology. 37:e15636-e15636
e15636 Background: Tyrosine-kinases (TKs) play key roles in cancer by acting as major components of various signaling pathways. Tyrosine kinase inhibitors (TKIs) act by inhibiting TKs, thereby modulating downstream signaling. Here we report a molecul
Autor:
Elena Poddubskaya, Alexey Aleshin, Lyudmila Makovskaia, Daria Allina, Maria Suntsova, Irina N. Kochergina-Nikitskaya, Marina Sekacheva, Viktoria Barbara, Madina Baranova, Dmitriy E. Kamashev
Publikováno v:
Cold Spring Harbor Molecular Case Studies
Ovarian cancer is the fifth leading cause of cancer-related female mortality and the most lethal gynecological cancer. In this report, we present a rare case of recurrent granulosa cell tumor (GCT) of the ovary. We describe the case of a 26-yr-old wo